Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex-Reference-Cited by-同舟云学术

Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex

Published:2004-09 Issue:6 Volume:44 Page:1311-1319
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kaul Sanjay,Coin Bryan,Hedayiti Amir,Yano Juliana,Cercek Bojan,Chyu Kuang-Y.,Shah Prediman K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. High density lipoprotein: the clinical implications of recent studies;Gordon;N Engl J Med,1989

2. Regression of atherosclerotic lesions by high-density lipoprotein plasma fraction in the cholesterol-fed rabbit;Badimon;J Clin Invest,1990

3. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse;Plump;Proc Natl Acad Sci USA,1994

4. High density lipoproteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport;von Eckardstein;Arterioscler Thromb Vasc Biol,2001

5. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis;Zeiher;Circulation,1994

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction;Current Atherosclerosis Reports;2023-07-07

2. Therapeutic effect of human ApoA‐I‐Milano variant in aged transgenic mouse model of Alzheimer's disease;British Journal of Pharmacology;2023-03-29

3. Circulating apo B to A1 ratio reflects the progression of chronic heart failure with different etiologies;2023-03-02

4. Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction;European Heart Journal - Cardiovascular Pharmacotherapy;2023-02-14

5. Expression of recombinant human Apolipoprotein A-IMilano in Nicotiana tabacum;Bioresources and Bioprocessing;2023-01-21